Assistant Professor, Pathology Faculty

University of Texas Medical Branch (UTMB)Galveston, TX
1d

About The Position

Working in integrative diagnostics focusing on digital pathology, informatics and AI in the John Sealy Diagnostic Center within the department of Pathology. Director of Translational Pathology and Diagnostic Innovation: Assay Development & Innovation Provide leadership to design, develop, and optimize cutting-edge molecular diagnostic assays: Liquid biopsy assays for solid tumors and hematological malignancies o NGS-based panels, digital PCR assays, and immunoassay platforms Multiplex assays for multi-organism detection (infectious disease applications) Drive innovation by evaluating and implementing emerging technologies (e.g., ultra-sensitive sequencing, methylation-based assays, single-cell and spatial approaches) Develop SOPs, QC/QA frameworks, and laboratory workflows for in-house testing Biomarker Discovery & Translation Lead biomarker discovery and validation efforts across oncology and non-oncology indications Translate research findings into clinically actionable assays Support precision medicine initiatives through integration of genomic, epigenomic, and proteomic biomarkers (multi-omics) Implement a unified vision for applying translational molecular biomarkers and anatomic/digital pathology biomarkers to clinical implementation. Clinical Trials & Companion Diagnostics Partner with clinical and translational teams to support biomarker-driven clinical trials Develop and implement companion diagnostics (CDx) strategies aligned with therapeutic development initiatives Industry Collaboration & Technology Integration Establish and manage collaborations with biotechnology, pharma, and diagnostic companies Evaluate external technologies and platforms for clinical adoption Lead validation and integration of partner-developed assays into clinical workflows

Requirements

  • PhD, MD/PhD in related field

Responsibilities

  • Working in integrative diagnostics focusing on digital pathology, informatics and AI
  • Director of Translational Pathology and Diagnostic Innovation: Assay Development & Innovation
  • Provide leadership to design, develop, and optimize cutting-edge molecular diagnostic assays
  • Liquid biopsy assays for solid tumors and hematological malignancies
  • NGS-based panels, digital PCR assays, and immunoassay platforms
  • Multiplex assays for multi-organism detection (infectious disease applications)
  • Drive innovation by evaluating and implementing emerging technologies (e.g., ultra-sensitive sequencing, methylation-based assays, single-cell and spatial approaches)
  • Develop SOPs, QC/QA frameworks, and laboratory workflows for in-house testing
  • Lead biomarker discovery and validation efforts across oncology and non-oncology indications
  • Translate research findings into clinically actionable assays
  • Support precision medicine initiatives through integration of genomic, epigenomic, and proteomic biomarkers (multi-omics)
  • Implement a unified vision for applying translational molecular biomarkers and anatomic/digital pathology biomarkers to clinical implementation.
  • Partner with clinical and translational teams to support biomarker-driven clinical trials
  • Develop and implement companion diagnostics (CDx) strategies aligned with therapeutic development initiatives
  • Establish and manage collaborations with biotechnology, pharma, and diagnostic companies
  • Evaluate external technologies and platforms for clinical adoption
  • Lead validation and integration of partner-developed assays into clinical workflows
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service